ERIC AGUIAR
CIK 1262325 · last filed 2025-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$794.3K
Companies
6
Total Filings
46
Lifetime Open-Market Net
$57.25M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBIO | Director | 6,589 | $66.80 | $440.1K | $0 | 7 | 2025-06-24 |
| BMEA | Director | — | $1.17 | — | $0 | 5 | 2025-06-13 |
| Invitae Corp (NVTA) Delisted | Director | 3,857,782 | $0.09 | $343.7K | -$2.32M | 15 | 2023-05-01 |
| Eidos Therapeutics, Inc. (EIDX) Delisted | Director | 24,575,501 | — | — | $55.01M | 5 | 2020-05-29 |
| BHVN | Director | 31,400 | $11.28 | $354.2K | -$3.10M | 13 | 2020-01-24 |
| Altimmune, Inc. (HAQ.WS) Delisted | 10%+ Owner | 250,000 | — | — | $7.66M | 1 | 2007-08-07 |
Recent Filings · Page 3 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-10 | BHVN | Mixed | +1,250 | -$1.34M | EDGAR |
| 2019-12-20 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2019-12-18 | BHVN | Mixed | — | -$121.5K | EDGAR |
| 2019-12-16 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2019-12-11 | BHVN | Mixed | — | -$139.8K | EDGAR |
| 2019-11-22 | BHVN | Mixed | — | -$155.2K | EDGAR |
| 2019-09-13 | BHVN | Mixed | — | -$194.9K | EDGAR |
| 2019-07-08 | Eidos Therapeutics, Inc. (EIDX) Delisted | Buy (P) | +882,353 | $26.38M | EDGAR |
| 2019-06-13 | Eidos Therapeutics, Inc. (EIDX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-29 | Eidos Therapeutics, Inc. (EIDX) Delisted | Buy (P) | +1,103,848 | $28.62M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.